Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Combined effect of weight gain within normal weight range and parental hypertension on the prevalence of hypertension; from the J-MICC Study.

Okada R, Kadomatsu Y, Tsukamoto M, Sasakabe T, Kawai S, Tamura T, Hishida A, Ikezaki H, Furusyo N, Tanaka K, Hara M, Suzuki S, Watanabe M, Takezaki T, Nishimoto D, Matsui D, Watanabe I, Kuriki K, Takashima N, Nakamura Y, Katsuura-Kamano S, Arisawa K, Mikami H, Nakamura Y, Oze I, Koyanagi YN, Naito M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.

J Hum Hypertens. 2019 Sep 3. doi: 10.1038/s41371-019-0230-y. [Epub ahead of print]

PMID:
31481698
2.

A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.

Kojima H, Nakamura S, Haraguchi T, Yoshida M, Habara M, Ikezaki H, Uchida T.

J Pharm Pharmacol. 2019 Sep;71(9):1384-1392. doi: 10.1111/jphp.13134. Epub 2019 Jul 5.

PMID:
31273801
3.

Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.

Ikezaki H, Fisher VA, Lim E, Ai M, Liu CT, Adrienne Cupples L, Nakajima K, Asztalos BF, Furusyo N, Schaefer EJ.

Clin Chem. 2019 Sep;65(9):1102-1114. doi: 10.1373/clinchem.2019.304600. Epub 2019 Jun 25.

PMID:
31239251
4.

Associations of Nutrient Patterns with the Prevalence of Metabolic Syndrome: Results from the Baseline Data of the Japan Multi-Institutional Collaborative Cohort Study.

Iwasaki Y, Arisawa K, Katsuura-Kamano S, Uemura H, Tsukamoto M, Kadomatsu Y, Okada R, Hishida A, Tanaka K, Hara M, Takezaki T, Shimatani K, Ozaki E, Koyama T, Suzuki S, Nakagawa-Senda H, Kuriki K, Miyagawa N, Kadota A, Ikezaki H, Furusyo N, Oze I, Ito H, Mikami H, Nakamura Y, Wakai K.

Nutrients. 2019 Apr 30;11(5). pii: E990. doi: 10.3390/nu11050990.

5.

Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population.

Uemura H, Katsuura-Kamano S, Iwasaki Y, Arisawa K, Hishida A, Okada R, Tamura T, Kubo Y, Ito H, Oze I, Shimanoe C, Nishida Y, Nakamura Y, Takashima N, Suzuki S, Nakagawa-Senda H, Nishimoto D, Takezaki T, Mikami H, Nakamura Y, Furusyo N, Ikezaki H, Ozaki E, Koyama T, Kuriki K, Endoh K, Naito M, Wakai K; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.

Endocrine. 2019 Jun;64(3):552-563. doi: 10.1007/s12020-019-01926-9. Epub 2019 Apr 22.

PMID:
31011988
6.

Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.

Commun Biol. 2019 Apr 8;2:115. doi: 10.1038/s42003-019-0339-0. eCollection 2019.

7.

Association of exposure level to passive smoking with hypertension among lifetime nonsmokers in Japan: a cross-sectional study.

Tamura T, Kadomatsu Y, Tsukamoto M, Okada R, Sasakabe T, Kawai S, Hishida A, Hara M, Tanaka K, Shimoshikiryo I, Takezaki T, Watanabe I, Matsui D, Nishiyama T, Suzuki S, Endoh K, Kuriki K, Kita Y, Katsuura-Kamano S, Arisawa K, Ikezaki H, Furusyo N, Koyanagi YN, Oze I, Nakamura Y, Mikami H, Naito M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.

Medicine (Baltimore). 2018 Nov;97(48):e13241. doi: 10.1097/MD.0000000000013241.

8.

Genomewide Association Study of Leisure-Time Exercise Behavior in Japanese Adults.

Hara M, Hachiya T, Sutoh Y, Matsuo K, Nishida Y, Shimanoe C, Tanaka K, Shimizu A, Ohnaka K, Kawaguchi T, Oze I, Matsuda F, Ito H, Kawai S, Hishida A, Okada R, Sasakabe T, Hirata A, Ibusuki R, Nindita Y, Furusyo N, Ikezaki H, Kuriyama N, Ozaki E, Mikami H, Nakamura Y, Suzuki S, Hosono A, Katsuura-Kamano S, Arisawa K, Kuriki K, Endoh K, Takashima N, Kadota A, Nakatochi M, Momozawa Y, Kubo M, Naito M, Wakai K.

Med Sci Sports Exerc. 2018 Dec;50(12):2433-2441. doi: 10.1249/MSS.0000000000001712.

9.

Are saving appearance responses typical communication patterns in Alzheimer's disease?

Matsushita M, Yatabe Y, Koyama A, Katsuya A, Ijichi D, Miyagawa Y, Ikezaki H, Furukawa N, Ikeda M, Hashimoto M.

PLoS One. 2018 May 23;13(5):e0197468. doi: 10.1371/journal.pone.0197468. eCollection 2018.

10.

Genome-Wide Association Study of Renal Function Traits: Results from the Japan Multi-Institutional Collaborative Cohort Study.

Hishida A, Nakatochi M, Akiyama M, Kamatani Y, Nishiyama T, Ito H, Oze I, Nishida Y, Hara M, Takashima N, Turin TC, Watanabe M, Suzuki S, Ibusuki R, Shimoshikiryo I, Nakamura Y, Mikami H, Ikezaki H, Furusyo N, Kuriki K, Endoh K, Koyama T, Matsui D, Uemura H, Arisawa K, Sasakabe T, Okada R, Kawai S, Naito M, Momozawa Y, Kubo M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.

Am J Nephrol. 2018;47(5):304-316. doi: 10.1159/000488946. Epub 2018 May 18.

PMID:
29779033
11.

Association of the Serum Endostatin Level, Renal Function, and Carotid Atherosclerosis of Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).

Kato Y, Furusyo N, Tanaka Y, Yamasaki S, Ueyama T, Takayama K, Mitsumoto-Kaseida F, Murata M, Ikezaki H, Hayashi J.

J Atheroscler Thromb. 2018 Sep 1;25(9):829-835. doi: 10.5551/jat.42234. Epub 2018 Feb 2.

12.

A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC Study.

Nakagawa-Senda H, Hachiya T, Shimizu A, Hosono S, Oze I, Watanabe M, Matsuo K, Ito H, Hara M, Nishida Y, Endoh K, Kuriki K, Katsuura-Kamano S, Arisawa K, Nindita Y, Ibusuki R, Suzuki S, Hosono A, Mikami H, Nakamura Y, Takashima N, Nakamura Y, Kuriyama N, Ozaki E, Furusyo N, Ikezaki H, Nakatochi M, Sasakabe T, Kawai S, Okada R, Hishida A, Naito M, Wakai K, Momozawa Y, Kubo M, Tanaka H.

Sci Rep. 2018 Jan 24;8(1):1493. doi: 10.1038/s41598-018-19914-w.

13.

The Utility of the Artificial Taste Sensor in Evaluating the Bitterness of Drugs: Correlation with Responses of Human TASTE2 Receptors (hTAS2Rs).

Haraguchi T, Uchida T, Yoshida M, Kojima H, Habara M, Ikezaki H.

Chem Pharm Bull (Tokyo). 2018;66(1):71-77. doi: 10.1248/cpb.c17-00619.

14.

Improved Durability and Sensitivity of Bitterness-Sensing Membrane for Medicines.

Wu X, Onitake H, Huang Z, Shiino T, Tahara Y, Yatabe R, Ikezaki H, Toko K.

Sensors (Basel). 2017 Nov 4;17(11). pii: E2541. doi: 10.3390/s17112541.

15.

Correlation between Thyroid Stimulating Hormone and Renal Function in Euthyroid Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).

Tanaka Y, Furusyo N, Kato Y, Ueyama T, Yamasaki S, Ikezaki H, Murata M, Hayashi J.

J Atheroscler Thromb. 2018 Apr 1;25(4):335-343. doi: 10.5551/jat.41251. Epub 2017 Oct 18.

16.

Genetic Variants of RAMP2 and CLR are Associated with Stroke.

Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Takeshita W, Iwai K, Watanabe Y, Nakatochi M, Shimanoe C, Tanaka K, Oze I, Ito H, Uemura H, Katsuura-Kamano S, Ibusuki R, Shimoshikiryo I, Takashima N, Kadota A, Kawai S, Sasakabe T, Okada R, Hishida A, Naito M, Kuriki K, Endoh K, Furusyo N, Ikezaki H, Suzuki S, Hosono A, Mikami H, Nakamura Y, Kubo M, Wakai K.

J Atheroscler Thromb. 2017 Dec 1;24(12):1267-1281. doi: 10.5551/jat.41517. Epub 2017 Sep 14.

17.

An advanced technique using an electronic taste-sensing system to evaluate the bitterness of orally disintegrating films and the evaluation of model films.

Takeuchi Y, Usui R, Ikezaki H, Tahara K, Takeuchi H.

Int J Pharm. 2017 Oct 5;531(1):179-190. doi: 10.1016/j.ijpharm.2017.07.073. Epub 2017 Aug 5.

PMID:
28789886
18.

Higher dietary cholesterol and ω-3 fatty acid intakes are associated with a lower success rate of Helicobacter pylori eradication therapy in Japan.

Ikezaki H, Furusyo N, Jacques PF, Shimizu M, Murata M, Schaefer EJ, Urita Y, Hayashi J.

Am J Clin Nutr. 2017 Aug;106(2):581-588. doi: 10.3945/ajcn.116.144873. Epub 2017 Jun 28.

PMID:
28659302
19.

Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.

Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.

J Clin Lipidol. 2017 Mar - Apr;11(2):348-356. doi: 10.1016/j.jacl.2017.01.014. Epub 2017 Feb 3.

PMID:
28502490
20.

Why do people with dementia pretend to know the correct answer? A qualitative study on the behaviour of toritsukuroi to keep up appearances.

Matsushita M, Yatabe Y, Koyama A, Ueno Y, Ijichi D, Ikezaki H, Hashimoto M, Furukawa N, Ikeda M.

Psychogeriatrics. 2017 Nov;17(6):377-381. doi: 10.1111/psyg.12253. Epub 2017 Apr 4.

PMID:
28378386
21.

Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study.

Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.

Sci Rep. 2016 Nov 10;6:36725. doi: 10.1038/srep36725.

22.

The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).

Shimizu M, Furusyo N, Tanaka Y, Kato Y, Mitsumoto-Kaseida F, Takayama K, Ura K, Hiramine S, Hayashi T, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J.

Int Urol Nephrol. 2016 Jun;48(6):851-7. doi: 10.1007/s11255-016-1258-3. Epub 2016 Mar 16.

PMID:
26984739
23.

Research on the Changes to the Lipid/Polymer Membrane Used in the Acidic Bitterness Sensor Caused by Preconditioning.

Harada Y, Noda J, Yatabe R, Ikezaki H, Toko K.

Sensors (Basel). 2016 Feb 15;16(2):230. doi: 10.3390/s16020230.

24.

Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.

Ikezaki H, Furusyo N, Hiramine S, Ura K, Mitsumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Murata M, Hayashi J.

Arch Virol. 2016 Mar;161(3):641-8. doi: 10.1007/s00705-015-2703-9. Epub 2015 Dec 12.

PMID:
26660164
25.

Analysis of a Lipid/Polymer Membrane for Bitterness Sensing with a Preconditioning Process.

Yatabe R, Noda J, Tahara Y, Naito Y, Ikezaki H, Toko K.

Sensors (Basel). 2015 Sep 4;15(9):22439-50. doi: 10.3390/s150922439.

26.

Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.

Ikezaki H, Nomura H, Furusyo N, Ogawa E, Kajiwara E, Takahashi K, Kawano A, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.

Hepatol Res. 2016 Mar;46(3):E174-80. doi: 10.1111/hepr.12555. Epub 2015 Sep 2.

PMID:
26189962
27.

Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.

Takayama K, Furusyo N, Ogawa E, Ikezaki H, Shimizu M, Murata M, Hayashi J.

World J Gastroenterol. 2015 Apr 21;21(15):4696-706. doi: 10.3748/wjg.v21.i15.4696.

28.

Glycated albumin as a diagnostic tool for diabetes in a general Japanese population.

Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J.

Metabolism. 2015 Jun;64(6):698-705. doi: 10.1016/j.metabol.2015.03.003. Epub 2015 Mar 14.

PMID:
25817605
29.

Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.

Shimizu M, Furusyo N, Ikezaki H, Ogawa E, Hayashi T, Ihara T, Harada Y, Toyoda K, Murata M, Hayashi J.

World J Gastroenterol. 2015 Feb 21;21(7):2116-23. doi: 10.3748/wjg.v21.i7.2116.

30.

Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS).

Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J.

Atherosclerosis. 2015 Feb;238(2):207-12. doi: 10.1016/j.atherosclerosis.2014.12.013. Epub 2014 Dec 9.

PMID:
25528429
31.

Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy.

Mitsumoto F, Murata M, Kato Y, Ura K, Takayama K, Hiramine S, Ikezaki H, Shimizu M, Toyoda K, Ogawa E, Aishima S, Furusyo N, Hayashi J.

Intern Med. 2014;53(18):2165-70. Epub 2014 Sep 15.

32.

Relationship between the amount of bitter substances adsorbed onto lipid/polymer membrane and the electric response of taste sensors.

Toko K, Hara D, Tahara Y, Yasuura M, Ikezaki H.

Sensors (Basel). 2014 Sep 2;14(9):16274-86. doi: 10.3390/s140916274.

33.

Development of a sweetness sensor for aspartame, a positively charged high-potency sweetener.

Yasuura M, Tahara Y, Ikezaki H, Toko K.

Sensors (Basel). 2014 Apr 23;14(4):7359-73. doi: 10.3390/s140407359.

34.

[Development of taste sensor for bitterness evaluation of drugs].

Ikezaki H.

Yakugaku Zasshi. 2014;134(3):313-6. Review. Japanese.

35.

A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.

Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J.

J Infect Chemother. 2014 May;20(5):320-4. doi: 10.1016/j.jiac.2013.11.006. Epub 2014 Jan 27.

PMID:
24477330
36.

The utility of urinary myo-inositol as a marker of glucose intolerance.

Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J.

Diabetes Res Clin Pract. 2014 Jan;103(1):88-96. doi: 10.1016/j.diabres.2013.11.018. Epub 2013 Dec 4.

PMID:
24377833
37.

Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia.

Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Okada K, Kainuma M, Kajiwara E, Takahashi K, Satoh T, Hayashi J.

J Viral Hepat. 2013 Dec;20(12):838-46. doi: 10.1111/jvh.12109. Epub 2013 May 26.

PMID:
24304453
38.

Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.

Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J.

Atherosclerosis. 2013 Dec;231(2):238-45. doi: 10.1016/j.atherosclerosis.2013.09.008. Epub 2013 Oct 1.

PMID:
24267234
39.

Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.

Uchida T, Yoshida M, Hazekawa M, Haraguchi T, Furuno H, Teraoka M, Ikezaki H.

J Pharm Pharmacol. 2013 Sep;65(9):1312-20. doi: 10.1111/jphp.12101. Epub 2013 Jul 10.

PMID:
23927469
40.

[A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].

Mitsumoto F, Murata M, Ikezaki H, Ogawa E, Taniai H, Toyoda K, Otaguro S, Kainuma M, Okada K, Furusyo N, Hayashi J.

Kansenshogaku Zasshi. 2012 Nov;86(6):763-7. Japanese.

PMID:
23367852
41.

The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).

Furusyo N, Ihara T, Hayashi T, Ikezaki H, Toyoda K, Ogawa E, Okada K, Kainuma M, Murata M, Hayashi J.

Endocrine. 2013 Jun;43(3):635-42. doi: 10.1007/s12020-012-9803-z. Epub 2012 Sep 22.

PMID:
23001602
42.

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

Furusyo N, Ogawa E, Sudoh M, Murata M, Ihara T, Hayashi T, Ikezaki H, Hiramine S, Mukae H, Toyoda K, Taniai H, Okada K, Kainuma M, Kajiwara E, Hayashi J.

J Hepatol. 2012 Dec;57(6):1186-92. doi: 10.1016/j.jhep.2012.08.003. Epub 2012 Aug 10.

PMID:
22889955
43.

Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS).

Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.

Int J Cardiol. 2013 Sep 1;167(5):2066-72. doi: 10.1016/j.ijcard.2012.05.045. Epub 2012 May 31.

PMID:
22658569
44.

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.

Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M, Hayashi J.

J Hepatol. 2012 Sep;57(3):534-40. doi: 10.1016/j.jhep.2012.04.027. Epub 2012 May 18.

PMID:
22613000
45.

Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptide.

Okada K, Furusyo N, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Kainuma M, Murata M, Hayashi J.

Endocrine. 2013 Feb;43(1):200-5. doi: 10.1007/s12020-012-9688-x. Epub 2012 May 13.

PMID:
22581254
46.

Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.

Toyoda K, Furusyo N, Ihara T, Ikezaki H, Urita Y, Hayashi J.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2117-24. doi: 10.1007/s10096-011-1543-0. Epub 2012 Feb 22.

PMID:
22354521
47.

Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients.

Furusyo N, Walaa AH, Eiraku K, Toyoda K, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Kainuma M, Murata M, Hayashi J.

Gut Liver. 2011 Dec;5(4):447-53. doi: 10.5009/gnl.2011.5.4.447. Epub 2011 Nov 21.

48.

Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.

Diabetologia. 2011 Dec;54(12):3028-36. doi: 10.1007/s00125-011-2310-6. Epub 2011 Sep 27.

PMID:
21947435
49.

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog.

Ogawa E, Furusyo N, Murata M, Ohnishi H, Toyoda K, Taniai H, Ihara T, Ikezaki H, Hayashi T, Kainuma M, Hayashi J.

Hepatol Res. 2011 Dec;41(12):1178-88. doi: 10.1111/j.1872-034X.2011.00869.x. Epub 2011 Sep 15.

PMID:
21917085
50.

Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis C.

Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ogawa E, Toyoda K, Taniai H, Kainuma M, Murata M, Hayashi J.

J Infect Chemother. 2011 Dec;17(6):737-43. doi: 10.1007/s10156-011-0249-7. Epub 2011 Apr 29.

PMID:
21528383

Supplemental Content

Loading ...
Support Center